Abstract
Immunotactoid glomerulopathy (ITG) describes a glomerular lesion with specific ultrastructural features of organized deposits, most often microtubular and/or in parallel arrays, usually with monotypic immunoglobulin staining. It is diagnosed in the absence of cryoglobulinemia and is often associated with underlying lymphoproliferative disease, which results in production of the pathogenic paraprotein with subsequent renal deposition. Treatment of such underlying diseases has shown beneficial results in some patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alpers CE (1992) Immunotactoid (microtubular) glomerulopathy: an entity distinct from fibrillary glomerulonephritis? Am J Kidney Dis 19:185–191
Alpers CE (1993) Fibrillary glomerulonephritis and immunotactoid glomerulopathy: two entities, not one. Am J Kidney Dis 22:448–451
Bridoux F, Hugue V, Coldefy O, Goujon JM, Bauwens M, Sechet A, Preud’Homme JL, Touchard G (2002) Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 62:1764–1775
Carles X, Rostaing L, Modesto A, Orfila C, Cisterne JM, Delisle MB, Durand D (2000) Successful treatment of recurrence of immunotactoid glomerulopathy in a kidney allograft recipient. Nephrol Dial Transplant 15:897–900
Fogo A, Quereshi N, Horn RG (1993) Morphological and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 22:367–377
Iskandar SS, Falk RJ, Jennette JC (1992) Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 42:1401–1407
Korbet SM, Schwartz MM, Lewis EJ (1991) Immunotactoid glomerulopathy. Am J Kidney Dis 17:247-257
Mallett A, Tang W, Hart G, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Campbell SB, Clayton PA, Johnson DW (2015) End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy – outcomes in 66 consecutive ANZDATA registry cases. Am J Nephrol 42:177–184
Nasr SH, Fidler ME, Cornell LD, Leung N, Cosio FG, Sheikh SS, Amir AA, Vrana JA, Theis JD, Dogan A, Sethi S (2012) Immunotactoid glomerulopathy: clinicopathologic and proteomic study. Nephrol Dial Transplant 27:4137–4146
Pronovost PH, Brady HR, Gunning ME, Espinoza O, Rennke HG (1996) Clinical features, predictors of disease progression and results of renal transplantation in fibrillary immunotactoid glomerulopathy. Nephrol Dial Transplant 11:837–842
Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D’Agati VD (2003) Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int 63:1450–1461
Sathyan S, Khan FN, Ranga KV (2009) A case of recurrent immunotactoid glomerulopathy in an allograft treated with Rituximab. Transplant Proc 41:3953–3955
Schwartz MM, Korbet SM, Lewis EJ (2002) Immunotactoid glomerulopathy. J Am Soc Nephrol 13:1390–1397
Sethi S, Theis JD, Vrana JA, Fervenza FC, Sethi A, Qian Q, Quint P, Leung N, Dogan A, Nasr SH (2013) Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol 8:915–921
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Kapp, M.E., Fogo, A.B. (2019). Immunotactoid Glomerulopathy. In: Trachtman, H., Herlitz, L., Lerma, E., Hogan, J. (eds) Glomerulonephritis. Springer, Cham. https://doi.org/10.1007/978-3-319-49379-4_36
Download citation
DOI: https://doi.org/10.1007/978-3-319-49379-4_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-49378-7
Online ISBN: 978-3-319-49379-4
eBook Packages: MedicineReference Module Medicine